Trials / Sponsors / S. Andrea Hospital

S. Andrea Hospital

Academic / Other · 16 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Active Not Recruiting	CRUCIAL-R Study : Cruciferous Vegetables Dietary Regimen in NMIBC Recurrence Free Survival, Bladder Cancer Recurrence	N/A	2025-10-17
Recruiting	Riluzole in Patients With Spinocerebellar Ataxia Type 7 SCA7	Phase 2 / Phase 3	2021-06-01
Unknown	CCM Italian Registry Heart Failure	—	2019-09-01
Recruiting	Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS) Multiple Sclerosis	Phase 2	2019-06-17
Completed	Body Cooling During Carotid Endarterectomy: No-profit, Open, Mono-centric, Feasibility Study Carotid Artery Diseases, Hypothermia, Stroke	N/A	2013-12-01
Completed	Barriers and Breakthroughs in IMPlementing Split Regimen OVEr Single Dose Colonoscopy: Bowel Preparation	—	2013-09-01
Unknown	Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Mucositis	Phase 4	2012-11-01
Terminated	Hydroxyurea in Primary Progressive Multiple Sclerosis Multiple Sclerosis	Phase 2 / Phase 3	2011-07-01
Unknown	Safety Study of Dabigatran in CADASIL CADASIL	Phase 2	2011-06-01
Completed	Efficacy of Riluzole in Hereditary Cerebellar Ataxia Cerebellar Ataxia	Phase 2 / Phase 3	2010-04-01
Completed	Interferon ß-1b Treatment by Cyclical Administration Multiple Sclerosis	Phase 2 / Phase 3	2005-11-01
Unknown	Use of Cannabinoids in Patients With Multiple Sclerosis Multiple Sclerosis	Phase 2	2005-07-01
Completed	Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia Hereditary Ataxia, Multiple Sclerosis, Cerebellar Ataxia	Phase 2	2005-06-01
Terminated	Gene Expression in MS Patients Before and During Treatment With Interferon-beta Multiple Sclerosis	—	2004-11-01
Unknown	Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients Multiple Sclerosis	Phase 2	2002-05-01
Completed	Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis Multiple Sclerosis	Phase 2 / Phase 3	2001-11-01